Shares of Sabra Health Care REIT Inc (NASDAQ:SBRA) have been given a consensus rating of “Hold” by the fourteen ratings firms that are covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and five have assigned a buy rating to the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $22.50.

SBRA has been the topic of a number of research reports. Mizuho restated a “buy” rating and issued a $26.00 price target on shares of Sabra Health Care REIT in a research note on Monday, August 13th. Raymond James raised their target price on Sabra Health Care REIT from $22.00 to $24.00 and gave the stock a “buy” rating in a report on Friday, August 17th. Jefferies Financial Group reaffirmed a “$21.91” rating and issued a $22.00 target price on shares of Sabra Health Care REIT in a report on Wednesday, July 18th. Zacks Investment Research raised Sabra Health Care REIT from a “hold” rating to a “buy” rating and set a $25.00 target price on the stock in a report on Wednesday, July 11th. Finally, BidaskClub cut Sabra Health Care REIT from a “buy” rating to a “hold” rating in a report on Wednesday, July 25th.

Shares of SBRA stock traded up $0.15 on Friday, reaching $22.66. The stock had a trading volume of 1,576,700 shares, compared to its average volume of 1,598,323. The company has a market cap of $4.10 billion, a P/E ratio of 9.33, a price-to-earnings-growth ratio of 2.72 and a beta of 0.63. Sabra Health Care REIT has a 1 year low of $15.77 and a 1 year high of $23.83. The company has a debt-to-equity ratio of 1.00, a current ratio of 3.16 and a quick ratio of 3.16.

Sabra Health Care REIT (NASDAQ:SBRA) last released its quarterly earnings results on Wednesday, August 8th. The real estate investment trust reported $1.08 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.33 by $0.75. The firm had revenue of $166.31 million for the quarter, compared to the consensus estimate of $166.62 million. Sabra Health Care REIT had a return on equity of 11.21% and a net margin of 62.60%. analysts expect that Sabra Health Care REIT will post 2.47 earnings per share for the current year.

The business also recently announced a quarterly dividend, which was paid on Friday, August 31st. Investors of record on Saturday, August 18th were issued a $0.45 dividend. The ex-dividend date was Thursday, August 16th. This represents a $1.80 dividend on an annualized basis and a yield of 7.94%. Sabra Health Care REIT’s dividend payout ratio is currently 74.07%.

Large investors have recently bought and sold shares of the business. Qube Research & Technologies Ltd bought a new stake in Sabra Health Care REIT during the second quarter valued at about $115,000. US Bancorp DE raised its holdings in Sabra Health Care REIT by 91.5% during the second quarter. US Bancorp DE now owns 5,699 shares of the real estate investment trust’s stock valued at $124,000 after acquiring an additional 2,723 shares during the period. Centaurus Financial Inc. bought a new stake in Sabra Health Care REIT during the second quarter valued at about $125,000. Goodwin Daniel L bought a new stake in Sabra Health Care REIT during the second quarter valued at about $207,000. Finally, Oxbow Advisors LLC bought a new stake in Sabra Health Care REIT during the second quarter valued at about $216,000. 90.40% of the stock is currently owned by institutional investors and hedge funds.

About Sabra Health Care REIT

As of June 30, 2018, Sabra's investment portfolio included 487 real estate properties held for investment (consisting of (i) 352 Skilled Nursing/Transitional Care facilities, (ii) 89 Senior Housing communities (?Senior Housing – Leased?), (iii) 24 Senior Housing communities operated by third-party property managers pursuant to property management agreements (?Senior Housing – Managed?) and (iv) 22 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a direct financing lease, 22 investments in loans receivable (consisting of (i) one mortgage loan, (ii) two construction loans, (iii) one mezzanine loan, (iv) one pre-development loan and (v) 17 other loans), 13 preferred equity investments and one investment in an unconsolidated joint venture that owns 172 Senior Housing – Managed communities.

See Also: Tariff

Analyst Recommendations for Sabra Health Care REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.